SB 1434
- Session Year: 2025-2026
- House: Senate
- Latest Version Date: 2025-04-30
Current Status:
In Progress
(2025-06-04: Act 175, on 06/04/2025 (Gov. Msg. No. 1275).)
Introduced
In Committee
First Chamber
In Committee
Second Chamber
Final Decking
Enacted
What does this bill do?
The bill redirects $934,000 from the Department of Health’s general administration appropriation (program HTH‑907) into the Universal Immunization Purchase Special Fund to support vaccine purchases.
The summary is provided by generative AI which can make mistakes. For original language, please view the details in the table below.
Establishes the Universal Immunization Funding Program as a universal funding model for immunization purchases by the Department of Health, to increase statewide access to immunizations for all persons under age sixty-five. Establishes the Universal Immunization Purchase Special Fund, into which fees collected from assessed entities and other sources of funding will be deposited, for purposes of bulk purchasing immunizations and administering the program. Appropriates funds. (CD2)
Establishes the Universal Immunization Funding Program as a universal funding model for immunization purchases by the Department of Health, to increase statewide access to immunizations for all persons under age sixty-five. Establishes the Universal Immunization Purchase Special Fund, into which fees collected from assessed entities and other sources of funding will be deposited, for purposes of bulk purchasing immunizations and administering the program. Appropriates funds. (CD1)
Establishes the Universal Immunization Purchase Program as a universal funding model for immunization purchases by the Department of Health, to increase statewide access to immunizations for all persons under age sixty-five. Establishes the Universal Immunization Purchase Special Fund, into which fees collected from assessed entities and other sources of funding will be deposited, for purposes of bulk purchasing immunizations and administering the program. Appropriates funds. Effective 7/1/3000. (HD1)
Establishes the Universal Immunization Funding Program for the purpose of administering immunizations to individuals in the State who are not eligible to receive immunizations at no cost through other programs. Establishes the Universal Immunization Purchase Special Fund into which fees will be deposited to finance the Universal Immunization Funding Program. Effective 12/31/2050. (SD1)
Establishes the Universal Immunization Purchase Special Fund into which the fees will be deposited to finance the distribution of immunizations free of charge to qualifying healthcare providers.
HOUSE OF REPRESENTATIVES
|
AMENDMENT TO: |
S.B. No. 1434, S.D. 1, H.D. 1, C.D. 1 |
||
|
|
|||
|
OFFERED BY: |
|
||
|
|
|||
|
DATE: |
|
||
"SECTION 4. Provided that of the general fund appropriation for health - general administration (program ID HTH 907), contained in the final version of House Bill No. 300 passed by the legislature in the regular session of 2025, the sum of $934,000 or so much thereof as may be necessary for fiscal year 2025-2026 shall be deposited into the universal immunization purchase special fund."
|
|
|
|
|
|
|
|
|
|
CARRIED |
|
FAILED TO CARRY |
|
WITHDRAWN |
|
|
|
|
|
||||
|
|
|
|
||||
|
|
|
|
||||
|
|
CHIEF CLERK, HOUSE OF REPRESENTATIVES |
|
||||
|
|
|
|
||||
SENATE FLOOR AMENDMENT
FLOOR AMENDMENT NO. Date
TO: Senate Bill No. 1434, S.D. 1, H.D. 1, C.D. 1
SECTION 1. Senate Bill No. 1434, S.D. 1, H.D. 1, C.D. 1, is amended by deleting the existing section 4 and inserting the following new section 4:
"SECTION 4. Provided that of the general fund appropriation for health - general administration (program ID HTH 907), contained in the final version of House Bill No. 300 passed by the legislature in the regular session of 2025, the sum of $934,000 or so much thereof as may be necessary for fiscal year 2025-2026 shall be deposited into the universal immunization purchase special fund."
|
Offered by: |
( ) Carried
|
|
|
( ) Failed to Carry
|
|
|
( ) Withdrawn
|
|
THE SENATE |
S.B. NO. |
1434 |
|
THIRTY-THIRD LEGISLATURE, 2025 |
S.D. 1 |
|
|
STATE OF HAWAII |
H.D. 1 |
|
|
|
C.D. 2 |
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO UNIVERSAL IMMUNIZATION FUNDING PROGRAM.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. The legislature finds that fourteen states have adopted programs known as "Universal Purchase" or "Universal Select" (collectively, UP), which provide state-purchased access to some or all recommended immunizations to children and adults in those states. UP immunization purchases occur at a discounted price through contracts otherwise intended for more established and familiar immunization purchasing programs such as the Vaccines For Children Program (Public Law 103-66) and Public Health Services Act, Section 317 Immunization Program (Public Law 78-410). Other varied state approaches include superseding private sources of coverage and assessing health insurance plans for the cost of the program and disallowing provider use of private immunization stock.
The legislature further finds that states with UP programs that allow state health officials to manage the supply of immunizations lowered health care providers' administrative costs and ensured that the states can quickly supply immunizations to vulnerable patient groups during emergencies or immunization shortages. The potential benefits to Hawaii's health care and public health system make investment in a UP program worthwhile.
The purpose of this Act is to establish a universal immunization funding program in the State.
SECTION 2. Chapter 325, Hawaii Revised Statutes, is amended by adding a new part to be appropriately designated and to read as follows:
"PART . UNIVERSAL IMMUNIZATION FUNDING PROGRAM
§325- Definitions. As used in this part:
"Adult covered lives" means all adults under the age of sixty-five who have immunizations covered:
(1) By an individual or group health insurance policy, plan, contract, or agreement issued or delivered in the State;
(2) By a group health insurance policy evidenced by a certificate of insurance issued or delivered to an individual residing in the State;
(3) By an employee benefit plan of a self-insured entity or a government plan for any employer or government entity that has an office or other worksite located in the State or has two or more employees; or
(4) As a participant or beneficiary of a health cost sharing program.
"Assessed entity" means an insurer that is not a medicare advantage health plan and is governed by article 10A of chapter 431, a nonprofit mutual benefit society governed by article 1 of chapter 432, a fraternal benefit society governed by article 2 of chapter 432, or a health maintenance organization governed by chapter 432D.
"Assessment" means the association member liability with respect to immunization costs determined in accordance with this part.
"Child covered lives" means all children aged eighteen years or younger who have immunizations covered:
(1) By an individual or group health insurance policy, plan, contract, or agreement issued or delivered in the State;
(2) By a group health insurance policy evidenced by a certificate of insurance issued or delivered to an individual residing in the State;
(3) By an employee benefit plan of a self-insured entity or a government plan for any employer or government entity that has an office or other worksite located in the State or has two or more employees; or
(4) As a participant or beneficiary of a health cost sharing program.
"Department" means the department of health.
"Director" means the director of health or the director's designee.
"Estimated adult immunization cost" means the estimated cost to the State for the purchase and distribution of adult immunizations.
"Estimated child immunization cost" means the estimated cost to the State for the purchase and distribution of child immunizations.
"Health cost sharing program" means any cost sharing or similar program that seeks to share the costs of health care services and that in the preceding twelve months has either coordinated payment for or reimbursed over $10,000 of costs for health care services delivered in the State or communicated by mail or electronic media to residents of the State concerning its potential participation.
"Immunization" means any preparation of killed microorganisms, living attenuated organisms, living fully virulent organisms, or part thereof, or any other treatment intended to trigger an immune response that is authorized by the United States Food and Drug Administration, recommended by the national Advisory Committee on Immunization Practices of the federal Centers for Disease Control and Prevention, or has been authorized for purchase by the director for the purposes of producing or increasing immunity to particular diseases. "Immunization" includes any other substance designated as such by order of the director.
"Program" means the universal immunization funding program established under this part.
"Provider" means a person licensed by the State to administer immunizations or provide health care services or a partnership or corporation or other entity made up of those persons.
"Vaccines for children program" means the federal entitlement program established under title 42 United States Code section 1396s, which provides immunizations at no charge for eligible children eighteen years of age or younger.
§325- Universal immunization funding program; established. (a) There is established within the department the universal immunization funding program for the purpose of providing immunizations to individuals in the State.
(b) The department may contract with other entities for any services needed to carry out the purposes of this part.
§325- Universal immunization purchase special fund; established. (a) There is established in the state treasury the universal immunization purchase special fund into which shall be deposited:
(1) Fees, fines, and cost reimbursements collected from assessed entities pursuant to this part;
(2) Appropriations made by the legislature;
(3) Grants, contracts, donations, and private contributions;
(4) Moneys from the federal Centers for Medicare and Medicaid Services and other federal agencies;
(5) All interest earned or accrued from the investment of moneys in the fund; and
(6) Any other moneys made available to the special fund from other sources.
(b) The fund shall be administered and expended by the department.
(c) Expenditures from the fund shall be used for the purchase of immunizations and the administration of the program.
§325- Assessments. (a) The director shall determine immunization assessment rates as follows:
(1) Provide estimated child immunization costs and estimated adult immunization costs, not covered by the vaccines for children program or any of its successors, for the succeeding fiscal year no later than ninety days before the commencement of each state fiscal year;
(2) Add estimates to cover the department's operating costs for the program;
(3) Add a reserve of up to ten per cent of the sum of the preceding fiscal year's program costs and for unanticipated costs;
(4) Add a working capital reserve in such amount as may be reasonably determined by the director;
(5) Subtract or add the amount of any surplus or deficit in the fund, including any net investment income earned, as of the end of the preceding state fiscal year; and
(6) Calculate the immunization assessment rates as a per‑child covered life per month and per-adult covered life per month amount to be self-reported and paid by all assessed entities by dividing the annual amount determined in accordance with paragraphs (1) through (5) by the number of children and adults, respectively, projected to be covered by the assessed entities during the succeeding program year, divided by twelve.
(b) No later than forty-five days following the close of each state fiscal year, the department shall provide an accounting of immunization purchase funds not covered by any state or other program to determine the final amount needed to cover the prior fiscal year.
Unless determined by the director, any assessed entity that would otherwise be responsible for reimbursement to any provider for any immunization administration shall be responsible for reporting the child covered life and adult covered life and for payment of the corresponding assessment to the department. The department shall establish by rule the frequency, schedule, and methodology of the assessments that the assessed entities shall be subject to.
(c) At any time after one full calendar year of operation under subsections (a) and (b), the director may make changes to the assessment collection mechanism. Any changes shall be reflected in an updated plan of operation available to the public.
(d) If an assessed entity has not paid in accordance with this section, interest shall accrue at one per cent per month, compounded monthly on or after the due date.
(e) The director may determine an interim assessment for new immunizations or public health emergencies and shall calculate a supplemental interim assessment using the methodology outlined under subsection (a) for regular assessments, but payable within forty-five days of the interim assessment notice. The director shall not impose more than one interim assessment per year, except in the case of a public health emergency declared in accordance with federal or state law.
(f) For purposes of assessments, medical loss ratio calculations, and reimbursement by plan sponsors, all association assessments shall be considered pharmaceutical or medical benefit costs and not regulatory or administrative costs.
(g) If the department discontinues operation of the program for any reason, any unexpended assessments, including unexpended funds from prior assessments in the universal immunization purchase special fund, shall be refunded to assessed entities in proportion to the current fiscal year's assessment rate.
§325- Reports and audits. (a) The department shall audit assessed entities and providers in accordance with the reporting and compliance requirements of the program. Each assessed entity shall report its number of child and adult covered lives according to a schedule determined by the director and respond to any requests by the director related to covered lives or assessments due. Any assessed entity that fails to respond to an audit request within ten business days of the receipt of notification of audit request shall be responsible for prompt payment of fees of any outside auditor engaged by the department to determine the information and shall make all records requested by the department-engaged auditors available for inspection and copying at the location within the State as specified by the auditor.
(b) Each provider administering immunizations in the State that are supplied via federal vaccination programs or the program shall report to the Hawaii immunization registry pursuant to section 325-122 any data related to immunizations as the department determines is necessary for disease prevention, control, and immunization inventory management and accountability purposes.
(c) Failure to cure non-compliance with any reporting, auditing, or assessment obligation to the department no later than thirty days from the postmarked date of written notice of noncompliance may subject the assessed entity to fines, fees, and other costs of enforcement established pursuant to subsection (d). Any monetary fine, fee, or cost reimbursement shall be remitted to the universal immunization purchase special fund.
(d) Any entity that violates this part shall be fined not more than $1,000 for each separate offense. Each day of violation shall constitute a separate offense. The assessed entity shall also pay for reasonable attorneys' fees and any other costs of enforcement under this section. Any action taken to impose or collect the penalty provided for in this subsection shall be considered a civil action.
§325- Immunity. Apart from liabilities of assessed entities pursuant to this part, there shall be no liability on the part of and no cause of action against the department, its independent contractors, or its employees for any action or omission in the course of operating the universal immunization purchase program.
§325- Rulemaking. The department may adopt rules pursuant to chapter 91 to carry out the purposes of this part.
§325- Available choices. The department shall purchase immunizations through the federal Centers for Disease Control and Prevention contracted price list, or other group purchasing negotiated discount rate, for which costs are funded pursuant to this part. The department may make purchases from available immunizations based on health care provider requests and shall not limit the immunizations the department purchases from those available at a discounted rate; provided that the department may choose to not purchase a specific immunization that has a low volume of statewide health care provider requests.
§325- Immunization cost reimbursement to providers; limits. This part shall have no impact on amounts paid to providers to administer immunizations. No provider may bill any assessed entity or any other person for any immunizations supplied at no cost by the State."
SECTION 3. Section 36-27, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:
"(a) Except as provided in this section, and notwithstanding any other law to the contrary, from time to time, the director of finance, for the purpose of defraying the prorated estimate of central service expenses of government in relation to all special funds, except the:
(1) Special out-of-school time instructional program fund under section 302A-1310;
(2) School cafeteria special funds of the department of education;
(3) Special funds of the University of Hawaii;
(4) Convention center enterprise special fund under section 201B-8;
(5) Special funds established by section 206E-6;
(6) Aloha Tower fund created by section 206J-17;
(7) Funds of the employees' retirement system created by section 88-109;
(8) Hawaii hurricane relief fund established under chapter 431P;
(9) Hawaii health systems corporation special funds and the subaccounts of its regional system boards;
(10) Universal service fund established under section 269‑42;
(11) Emergency and budget reserve fund under section 328L‑3;
(12) Public schools special fees and charges fund under section 302A-1130;
(13) Sport fish special fund under section 187A-9.5;
(14) Neurotrauma special fund under section 321H-4;
(15) Glass advance disposal fee established by section 342G-82;
(16) Center for nursing special fund under section 304A‑2163;
(17) Passenger facility charge special fund established by section 261-5.5;
(18) Solicitation of funds for charitable purposes special fund established by section 467B-15;
(19) Land conservation fund established by section 173A-5;
(20) Court interpreting services revolving fund under section 607-1.5;
(21) Trauma system special fund under section 321-22.5;
(22) Hawaii cancer research special fund;
(23) Community health centers special fund;
(24) Emergency medical services special fund;
(25) Rental motor vehicle customer facility charge special fund established under section 261-5.6;
(26) Shared services technology special fund under section 27-43;
(27) Automated victim information and notification system special fund established under section 353-136;
(28) Deposit beverage container deposit special fund under section 342G-104;
(29) Hospital sustainability program special fund under section 346G-4;
(30) Nursing facility sustainability program special fund under section 346F-4;
(31) Hawaii 3R's school improvement fund under section 302A-1502.4;
(32) After-school plus program revolving fund under section 302A-1149.5;
(33) Civil monetary penalty special fund under section
321‑30.2; [and]
[[](34)[]]Stadium development special fund
under section 109‑3.5[,]; and
(35) Universal immunization purchase special fund under section 325- ,
shall deduct five per cent of all receipts of all other special funds, which deduction shall be transferred to the general fund of the State and become general realizations of the State. All officers of the State and other persons having power to allocate or disburse any special funds shall cooperate with the director in effecting these transfers. To determine the proper revenue base upon which the central service assessment is to be calculated, the director shall adopt rules pursuant to chapter 91 for the purpose of suspending or limiting the application of the central service assessment of any fund. No later than twenty days prior to the convening of each regular session of the legislature, the director shall report all central service assessments made during the preceding fiscal year."
SECTION 4. Provided that of the general fund appropriation for health - general administration (program ID HTH 907), contained in the final version of House Bill No. 300 passed by the legislature in the regular session of 2025, the sum of $934,000 or so much thereof as may be necessary for fiscal year 2025-2026 shall be deposited into the universal immunization purchase special fund.
SECTION 5. There is appropriated out of the universal immunization purchase special fund the sum of $934,000 or so much thereof as may be necessary for fiscal year 2025-2026 for the purchase of immunizations and the administration of the universal immunization funding program.
The sum appropriated shall be expended by the department of health for the purposes of this Act.
SECTION 6. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 7. This Act shall take effect on July 1, 2025.
Report Title:
Universal Immunization Funding Program; Immunization Purchasing; Universal Immunization Purchase Special Fund; Appropriation
Description:
Establishes the Universal Immunization Funding Program as a universal funding model for immunization purchases by the Department of Health, to increase statewide access to immunizations for all persons under age sixty-five. Establishes the Universal Immunization Purchase Special Fund, into which fees collected from assessed entities and other sources of funding will be deposited, for purposes of bulk purchasing immunizations and administering the program. Appropriates funds. (CD2)
The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
|
THE SENATE |
S.B. NO. |
1434 |
|
THIRTY-THIRD LEGISLATURE, 2025 |
S.D. 1 |
|
|
STATE OF HAWAII |
H.D. 1 |
|
|
|
C.D. 1 |
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO UNIVERSAL IMMUNIZATION FUNDING PROGRAM.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. The legislature finds that fourteen states have adopted programs known as "Universal Purchase" or "Universal Select" (collectively, UP), which provide state-purchased access to some or all recommended immunizations to children and adults in those states. UP immunization purchases occur at a discounted price through contracts otherwise intended for more established and familiar immunization purchasing programs such as the Vaccines For Children Program (Public Law 103-66) and Public Health Services Act, Section 317 Immunization Program (Public Law 78-410). Other varied state approaches include superseding private sources of coverage and assessing health insurance plans for the cost of the program and disallowing provider use of private immunization stock.
The legislature further finds that states with UP programs that allow state health officials to manage the supply of immunizations lowered health care providers' administrative costs and ensured that the states can quickly supply immunizations to vulnerable patient groups during emergencies or immunization shortages. The potential benefits to Hawaii's health care and public health system make investment in a UP program worthwhile.
The purpose of this Act is to establish a universal immunization funding program in the State.
SECTION 2. Chapter 325, Hawaii Revised Statutes, is amended by adding a new part to be appropriately designated and to read as follows:
"PART . UNIVERSAL IMMUNIZATION FUNDING PROGRAM
§325- Definitions. As used in this part:
"Adult covered lives" means all adults under the age of sixty-five who have immunizations covered:
(1) By an individual or group health insurance policy, plan, contract, or agreement issued or delivered in the State;
(2) By a group health insurance policy evidenced by a certificate of insurance issued or delivered to an individual residing in the State;
(3) By an employee benefit plan of a self-insured entity or a government plan for any employer or government entity that has an office or other worksite located in the State or has two or more employees; or
(4) As a participant or beneficiary of a health cost sharing program.
"Assessed entity" means an insurer that is not a medicare advantage health plan and is governed by article 10A of chapter 431, a nonprofit mutual benefit society governed by article 1 of chapter 432, a fraternal benefit society governed by article 2 of chapter 432, or a health maintenance organization governed by chapter 432D.
"Assessment" means the association member liability with respect to immunization costs determined in accordance with this part.
"Child covered lives" means all children aged eighteen years or younger who have immunizations covered:
(1) By an individual or group health insurance policy, plan, contract, or agreement issued or delivered in the State;
(2) By a group health insurance policy evidenced by a certificate of insurance issued or delivered to an individual residing in the State;
(3) By an employee benefit plan of a self-insured entity or a government plan for any employer or government entity that has an office or other worksite located in the State or has two or more employees; or
(4) As a participant or beneficiary of a health cost sharing program.
"Department" means the department of health.
"Director" means the director of health or the director's designee.
"Estimated adult immunization cost" means the estimated cost to the State for the purchase and distribution of adult immunizations.
"Estimated child immunization cost" means the estimated cost to the State for the purchase and distribution of child immunizations.
"Health cost sharing program" means any cost sharing or similar program that seeks to share the costs of health care services and that in the preceding twelve months has either coordinated payment for or reimbursed over $10,000 of costs for health care services delivered in the State or communicated by mail or electronic media to residents of the State concerning its potential participation.
"Immunization" means any preparation of killed microorganisms, living attenuated organisms, living fully virulent organisms, or part thereof, or any other treatment intended to trigger an immune response that is authorized by the United States Food and Drug Administration, recommended by the national Advisory Committee on Immunization Practices of the federal Centers for Disease Control and Prevention, or has been authorized for purchase by the director for the purposes of producing or increasing immunity to particular diseases. "Immunization" includes any other substance designated as such by order of the director.
"Program" means the universal immunization funding program established under this part.
"Provider" means a person licensed by the State to administer immunizations or provide health care services or a partnership or corporation or other entity made up of those persons.
"Vaccines for children program" means the federal entitlement program established under title 42 United States Code section 1396s, which provides immunizations at no charge for eligible children eighteen years of age or younger.
§325- Universal immunization funding program; established. (a) There is established within the department the universal immunization funding program for the purpose of providing immunizations to individuals in the State.
(b) The department may contract with other entities for any services needed to carry out the purposes of this part.
§325- Universal immunization purchase special fund; established. (a) There is established in the state treasury the universal immunization purchase special fund into which shall be deposited:
(1) Fees, fines, and cost reimbursements collected from assessed entities pursuant to this part;
(2) Appropriations made by the legislature;
(3) Grants, contracts, donations, and private contributions;
(4) Moneys from the federal Centers for Medicare and Medicaid Services and other federal agencies;
(5) All interest earned or accrued from the investment of moneys in the fund; and
(6) Any other moneys made available to the special fund from other sources.
(b) The fund shall be administered and expended by the department.
(c) Expenditures from the fund shall be used for the purchase of immunizations and the administration of the program.
§325- Assessments. (a) The director shall determine immunization assessment rates as follows:
(1) Provide estimated child immunization costs and estimated adult immunization costs, not covered by the vaccines for children program or any of its successors, for the succeeding fiscal year no later than ninety days before the commencement of each state fiscal year;
(2) Add estimates to cover the department's operating costs for the program;
(3) Add a reserve of up to ten per cent of the sum of the preceding fiscal year's program costs and for unanticipated costs;
(4) Add a working capital reserve in such amount as may be reasonably determined by the director;
(5) Subtract or add the amount of any surplus or deficit in the fund, including any net investment income earned, as of the end of the preceding state fiscal year; and
(6) Calculate the immunization assessment rates as a per‑child covered life per month and per-adult covered life per month amount to be self-reported and paid by all assessed entities by dividing the annual amount determined in accordance with paragraphs (1) through (5) by the number of children and adults, respectively, projected to be covered by the assessed entities during the succeeding program year, divided by twelve.
(b) No later than forty-five days following the close of each state fiscal year, the department shall provide an accounting of immunization purchase funds not covered by any state or other program to determine the final amount needed to cover the prior fiscal year.
Unless determined by the director, any assessed entity that would otherwise be responsible for reimbursement to any provider for any immunization administration shall be responsible for reporting the child covered life and adult covered life and for payment of the corresponding assessment to the department. The department shall establish by rule the frequency, schedule, and methodology of the assessments that the assessed entities shall be subject to.
(c) At any time after one full calendar year of operation under subsections (a) and (b), the director may make changes to the assessment collection mechanism. Any changes shall be reflected in an updated plan of operation available to the public.
(d) If an assessed entity has not paid in accordance with this section, interest shall accrue at one per cent per month, compounded monthly on or after the due date.
(e) The director may determine an interim assessment for new immunizations or public health emergencies and shall calculate a supplemental interim assessment using the methodology outlined under subsection (a) for regular assessments, but payable within forty-five days of the interim assessment notice. The director shall not impose more than one interim assessment per year, except in the case of a public health emergency declared in accordance with federal or state law.
(f) For purposes of assessments, medical loss ratio calculations, and reimbursement by plan sponsors, all association assessments shall be considered pharmaceutical or medical benefit costs and not regulatory or administrative costs.
(g) If the department discontinues operation of the program for any reason, any unexpended assessments, including unexpended funds from prior assessments in the universal immunization purchase special fund, shall be refunded to assessed entities in proportion to the current fiscal year's assessment rate.
§325- Reports and audits. (a) The department shall audit assessed entities and providers in accordance with the reporting and compliance requirements of the program. Each assessed entity shall report its number of child and adult covered lives according to a schedule determined by the director and respond to any requests by the director related to covered lives or assessments due. Any assessed entity that fails to respond to an audit request within ten business days of the receipt of notification of audit request shall be responsible for prompt payment of fees of any outside auditor engaged by the department to determine the information and shall make all records requested by the department-engaged auditors available for inspection and copying at the location within the State as specified by the auditor.
(b) Each provider administering immunizations in the State that are supplied via federal vaccination programs or the program shall report to the Hawaii immunization registry pursuant to section 325-122 any data related to immunizations as the department determines is necessary for disease prevention, control, and immunization inventory management and accountability purposes.
(c) Failure to cure non-compliance with any reporting, auditing, or assessment obligation to the department no later than thirty days from the postmarked date of written notice of noncompliance may subject the assessed entity to fines, fees, and other costs of enforcement established pursuant to subsection (d). Any monetary fine, fee, or cost reimbursement shall be remitted to the universal immunization purchase special fund.
(d) Any entity that violates this part shall be fined not more than $1,000 for each separate offense. Each day of violation shall constitute a separate offense. The assessed entity shall also pay for reasonable attorneys' fees and any other costs of enforcement under this section. Any action taken to impose or collect the penalty provided for in this subsection shall be considered a civil action.
§325- Immunity. Apart from liabilities of assessed entities pursuant to this part, there shall be no liability on the part of and no cause of action against the department, its independent contractors, or its employees for any action or omission in the course of operating the universal immunization purchase program.
§325- Rulemaking. The department may adopt rules pursuant to chapter 91 to carry out the purposes of this part.
§325- Available choices. The department shall purchase immunizations through the federal Centers for Disease Control and Prevention contracted price list, or other group purchasing negotiated discount rate, for which costs are funded pursuant to this part. The department may make purchases from available immunizations based on health care provider requests and shall not limit the immunizations the department purchases from those available at a discounted rate; provided that the department may choose to not purchase a specific immunization that has a low volume of statewide health care provider requests.
§325- Immunization cost reimbursement to providers; limits. This part shall have no impact on amounts paid to providers to administer immunizations. No provider may bill any assessed entity or any other person for any immunizations supplied at no cost by the State."
SECTION 3. Section 36-27, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:
"(a) Except as provided in this section, and notwithstanding any other law to the contrary, from time to time, the director of finance, for the purpose of defraying the prorated estimate of central service expenses of government in relation to all special funds, except the:
(1) Special out-of-school time instructional program fund under section 302A-1310;
(2) School cafeteria special funds of the department of education;
(3) Special funds of the University of Hawaii;
(4) Convention center enterprise special fund under section 201B-8;
(5) Special funds established by section 206E-6;
(6) Aloha Tower fund created by section 206J-17;
(7) Funds of the employees' retirement system created by section 88-109;
(8) Hawaii hurricane relief fund established under chapter 431P;
(9) Hawaii health systems corporation special funds and the subaccounts of its regional system boards;
(10) Universal service fund established under section 269‑42;
(11) Emergency and budget reserve fund under section 328L‑3;
(12) Public schools special fees and charges fund under section 302A-1130;
(13) Sport fish special fund under section 187A-9.5;
(14) Neurotrauma special fund under section 321H-4;
(15) Glass advance disposal fee established by section 342G-82;
(16) Center for nursing special fund under section 304A‑2163;
(17) Passenger facility charge special fund established by section 261-5.5;
(18) Solicitation of funds for charitable purposes special fund established by section 467B-15;
(19) Land conservation fund established by section 173A-5;
(20) Court interpreting services revolving fund under section 607-1.5;
(21) Trauma system special fund under section 321-22.5;
(22) Hawaii cancer research special fund;
(23) Community health centers special fund;
(24) Emergency medical services special fund;
(25) Rental motor vehicle customer facility charge special fund established under section 261-5.6;
(26) Shared services technology special fund under section 27-43;
(27) Automated victim information and notification system special fund established under section 353-136;
(28) Deposit beverage container deposit special fund under section 342G-104;
(29) Hospital sustainability program special fund under section 346G-4;
(30) Nursing facility sustainability program special fund under section 346F-4;
(31) Hawaii 3R's school improvement fund under section 302A-1502.4;
(32) After-school plus program revolving fund under section 302A-1149.5;
(33) Civil monetary penalty special fund under
section 321‑30.2; [and]
[[](34)[]]Stadium
development special fund under section 109‑3.5[,]; and
(35) Universal immunization purchase special fund under section 325- ,
shall deduct five per cent of all receipts of all other special funds, which deduction shall be transferred to the general fund of the State and become general realizations of the State. All officers of the State and other persons having power to allocate or disburse any special funds shall cooperate with the director in effecting these transfers. To determine the proper revenue base upon which the central service assessment is to be calculated, the director shall adopt rules pursuant to chapter 91 for the purpose of suspending or limiting the application of the central service assessment of any fund. No later than twenty days prior to the convening of each regular session of the legislature, the director shall report all central service assessments made during the preceding fiscal year."
SECTION 4. There is appropriated out of the general revenues of the State of Hawaii the sum of $934,000 or so much thereof as may be necessary for the fiscal year 2025-2026 to be deposited into the universal immunization purchase special fund.
SECTION 5. There is appropriated out of the universal immunization purchase special fund the sum of $934,000 or so much thereof as may be necessary for fiscal year 2025-2026 for the purchase of immunizations and the administration of the universal immunization funding program.
The sum appropriated shall be expended by the department of health for the purposes of this Act.
SECTION 6. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 7. This Act shall take effect on July 1, 2025.
Report Title:
Universal Immunization Funding Program; Immunization Purchasing; Universal Immunization Purchase Special Fund; Appropriation
Description:
Establishes the Universal Immunization Funding Program as a universal funding model for immunization purchases by the Department of Health, to increase statewide access to immunizations for all persons under age sixty-five. Establishes the Universal Immunization Purchase Special Fund, into which fees collected from assessed entities and other sources of funding will be deposited, for purposes of bulk purchasing immunizations and administering the program. Appropriates funds. (CD1)
The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
|
THE SENATE |
S.B. NO. |
1434 |
|
THIRTY-THIRD LEGISLATURE, 2025 |
S.D. 1 |
|
|
STATE OF HAWAII |
H.D. 1 |
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO UNIVERSAL IMMUNIZATION FUNDING PROGRAM.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. The legislature finds that fourteen states have adopted programs known as "Universal Purchase" or "Universal Select" (collectively, UP), which provide state-purchased access to some or all recommended immunizations to children and adults in those states. UP immunization purchases occur at a discounted price through contracts otherwise intended for more established and familiar immunization purchasing programs such as the Vaccines For Children Program (Public Law 103-66) and Public Health Services Act, Section 317 Immunization Program (Public Law 78-410). Other varied state approaches include superseding private sources of coverage and assessing health insurance plans for the cost of the program and disallowing provider use of private immunization stock.
The legislature further finds that states with UP programs that allow state health officials to manage the supply of immunizations lowered health care providers' administrative costs and ensured that the states can quickly supply immunizations to vulnerable patient groups during emergencies or immunization shortages. The potential benefits to Hawaii's health care and public health system make investment in a UP program worthwhile.
The purpose of this Act is to establish a universal immunization funding program in the State.
SECTION 2. Chapter 325, Hawaii Revised Statutes, is amended by adding a new part to be appropriately designated and to read as follows:
"PART . UNIVERSAL IMMUNIZATION FUNDING PROGRAM
§325- Definitions. As used in this part:
"Adult covered lives" means all adults under the age of sixty-five who have immunizations covered:
(1) By an individual or group health insurance policy, plan, contract, or agreement issued or delivered in the State;
(2) By a group health insurance policy evidenced by a certificate of insurance issued or delivered to an individual residing in the State;
(3) By an employee benefit plan of a self-insured entity or a government plan for any employer or government entity that has an office or other worksite located in the State or has two or more employees; or
(4) As a participant or beneficiary of a health cost sharing program.
"Assessed entity" means an insurer that is not a medicare advantage health plan and is governed by article 10A of chapter 431, a nonprofit mutual benefit society governed by article 1 of chapter 432, a fraternal benefit society governed by article 2 of chapter 432, or a health maintenance organization governed by chapter 432D.
"Assessment" means the association member liability with respect to immunization costs determined in accordance with this part.
"Child covered lives" means all children aged eighteen years or younger who have immunizations covered:
(1) By an individual or group health insurance policy, plan, contract, or agreement issued or delivered in the State;
(2) By a group health insurance policy evidenced by a certificate of insurance issued or delivered to an individual residing in the State;
(3) By an employee benefit plan of a self-insured entity or a government plan for any employer or government entity that has an office or other worksite located in the State or has two or more employees; or
(4) As a participant or beneficiary of a health cost sharing program.
"Department" means the department of health.
"Director" means the director of health or the director's designee.
"Estimated adult immunization cost" means the estimated cost to the State for the purchase and distribution of adult immunizations.
"Estimated child immunization cost" means the estimated cost to the State for the purchase and distribution of child immunizations.
"Health cost sharing program" means any cost sharing or similar program that seeks to share the costs of health care services and that in the preceding twelve months has either coordinated payment for or reimbursed over $10,000 of costs for health care services delivered in the State or communicated by mail or electronic media to residents of the State concerning its potential participation.
"Immunization" means any preparation of killed microorganisms, living attenuated organisms, living fully virulent organisms, or part thereof, or any other treatment intended to trigger an immune response that is authorized by the United States Food and Drug Administration, recommended by the national Advisory Committee on Immunization Practices of the federal Centers for Disease Control and Prevention, or has been authorized for purchase by the director for the purposes of producing or increasing immunity to particular diseases. "Immunization" includes any other substance designated as such by order of the director.
"Program" means the universal immunization funding program established under this part.
"Provider" means a person licensed by the State to administer immunizations or provide health care services or a partnership or corporation or other entity made up of those persons.
"Vaccines for children program" means the federal entitlement program established under title 42 United States Code section 1396s, which provides immunizations at no charge for eligible children eighteen years of age or younger.
§325- Universal immunization funding program; established. (a) There is established within the department the universal immunization funding program for the purpose of providing immunizations to individuals in the State.
(b) The department may contract with other entities for any services needed to carry out the purposes of this part.
§325- Universal immunization purchase special fund; established. (a) There is established in the state treasury the universal immunization purchase special fund into which shall be deposited:
(1) Fees, fines, and cost reimbursements collected from assessed entities pursuant to this part;
(2) Appropriations made by the legislature;
(3) Grants, contracts, donations, and private contributions;
(4) Moneys from the federal Centers for Medicare and Medicaid Services and other federal agencies;
(5) All interest earned or accrued from the investment of moneys in the special fund; and
(6) Any other moneys made available to the special fund from other sources.
(b) The fund shall be administered and expended by the department.
(c) Expenditures from the fund shall be used for the purchase of immunizations and the administration of the program.
§325- Assessments. (a) The director shall determine immunization assessment rates as follows:
(1) Provide estimated child immunization costs and estimated adult immunization costs, not covered by the vaccines for children program or any of its successors, for the succeeding fiscal year no later than ninety days before the commencement of each state fiscal year;
(2) Add estimates to cover the department's operating costs for the universal immunization funding program;
(3) Add a reserve of up to ten per cent of the sum of the preceding fiscal year's program costs and for unanticipated costs;
(4) Add a working capital reserve in such amount as may be reasonably determined by the director;
(5) Subtract or add the amount of any surplus or deficit in the fund, including any net investment income earned, as of the end of the preceding state fiscal year; and
(6) Calculate the immunization assessment rates as a per-child covered life per month and per-adult covered life per month amount to be self-reported and paid by all assessed entities by dividing the annual amount determined in accordance with paragraphs (1) to (5) by the number of children and adults, respectively, projected to be covered by the assessed entities during the succeeding program year, divided by twelve.
(b) No later than forty-five days following the close of each state fiscal year, the department shall provide an accounting of immunization purchase funds not covered by any state or other program to determine the final amount needed to cover the prior fiscal year.
Unless determined by the director, any assessed entity that would otherwise be responsible for reimbursement to any provider for any immunization administration shall be responsible for reporting the child covered life and adult covered life and for payment of the corresponding assessment to the department. The department shall establish by rule the frequency, schedule, and methodology of the assessments that the assessed entities shall be subject to.
(c) At any time after one full calendar year of operation under subsections (a) and (b), the director may make changes to the assessment collection mechanism. Any changes shall be reflected in an updated plan of operation available to the public.
(d) If an assessed entity has not paid in accordance with this section, interest shall accrue at one per cent per month, compounded monthly on or after the due date.
(e) The director may determine an interim assessment for new immunizations or public health emergencies and shall calculate a supplemental interim assessment using the methodology outlined under subsection (a) for regular assessments, but payable within forty-five days of the interim assessment notice. The director shall not impose more than one interim assessment per year, except in the case of a public health emergency declared in accordance with federal or state law.
(f) For purposes of assessments, medical loss ratio calculations, and reimbursement by plan sponsors, all association assessments shall be considered pharmaceutical or medical benefit costs and not regulatory or administrative costs.
(g) If the department discontinues operation of the program for any reason, any unexpended assessments, including unexpended funds from prior assessments in the universal immunization purchase special fund, shall be refunded to assessed entities in proportion to the current fiscal year's assessment rate.
§325- Reports and audits. (a) The department shall audit assessed entities and providers in accordance with the reporting and compliance requirements of the program. Each assessed entity shall report its number of child and adult covered lives according to a schedule determined by the director and respond to any requests by the director related to covered lives or assessments due. Any assessed entity that fails to respond to an audit request within ten business days of the receipt of notification of audit request shall be responsible for prompt payment of fees of any outside auditor engaged by the department to determine the information and shall make all records requested by the department-engaged auditors available for inspection and copying at the location within the State as specified by the auditor.
(b) Each provider administering immunizations in the State that are supplied via federal vaccination programs or the program shall report to the Hawaii immunization registry pursuant to section 325-122 any data related to immunizations as the department determines is necessary for disease prevention, control, and immunization inventory management and accountability purposes.
(c) Failure to cure non-compliance with any reporting, auditing, or assessment obligation to the department no later than thirty days from the postmarked date of written notice of noncompliance may subject the assessed entity to fines, fees, and other costs of enforcement established pursuant to subsection (d). Any monetary fine, fee, or cost reimbursement shall be remitted to the universal immunization purchase special fund.
(d) Any entity that violates this chapter shall be fined not more than $1,000 for each separate offense. Each day of violation shall constitute a separate offense. The assessed entity shall also pay for reasonable attorneys' fees and any other costs of enforcement under this section. Any action taken to impose or collect the penalty provided for in this subsection shall be considered a civil action.
§325- Immunity. Apart from liabilities of assessed entities pursuant to this part, there shall be no liability on the part of and no cause of action against the department, its independent contractors, or its employees for any action or omission in the course of operating the universal immunization purchase program.
§325- Rulemaking. The department may adopt rules pursuant to chapter 91 to carry out the purposes of this part.
§325- Available choices. The department shall purchase immunizations through the federal Centers for Disease Control and Prevention contracted price list, or other group purchasing negotiated discount rate, for which costs are funded pursuant to this part. The department may make purchases from available immunizations based on health care provider requests and shall not limit the immunizations the department purchases from those available at a discounted rate; provided that the department may choose to not purchase a specific immunization that has a low volume of statewide health care provider requests.
§325- Immunization cost reimbursement to providers; limits. This part shall have no impact on amounts paid to providers to administer immunizations. No provider may bill any assessed entity or any other person for any immunizations supplied at no cost by the State."
SECTION 3. Section 36-27, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:
"(a) Except as provided in this section, and notwithstanding any other law to the contrary, from time to time, the director of finance, for the purpose of defraying the prorated estimate of central service expenses of government in relation to all special funds, except the:
(1) Special out-of-school time instructional program fund under section 302A-1310;
(2) School cafeteria special funds of the department of education;
(3) Special funds of the University of Hawaii;
(4) Convention center enterprise special fund under section 201B-8;
(5) Special funds established by section 206E-6;
(6) Aloha Tower fund created by section 206J-17;
(7) Funds of the employees' retirement system created by section 88-109;
(8) Hawaii hurricane relief fund established under chapter 431P;
(9) Hawaii health systems corporation special funds and the subaccounts of its regional system boards;
(10) Universal service fund established under section 269-42;
(11) Emergency and budget reserve fund under section 328L-3;
(12) Public schools special fees and charges fund under section 302A-1130;
(13) Sport fish special fund under section 187A-9.5;
(14) Neurotrauma special fund under section 321H-4;
(15) Glass advance disposal fee established by section 342G-82;
(16) Center for nursing special fund under section 304A-2163;
(17) Passenger facility charge special fund established by section 261-5.5;
(18) Solicitation of funds for charitable purposes special fund established by section 467B-15;
(19) Land conservation fund established by section 173A-5;
(20) Court interpreting services revolving fund under section 607-1.5;
(21) Trauma system special fund under section 321-22.5;
(22) Hawaii cancer research special fund;
(23) Community health centers special fund;
(24) Emergency medical services special fund;
(25) Rental motor vehicle customer facility charge special fund established under section 261-5.6;
(26) Shared services technology special fund under section 27-43;
(27) Automated victim information and notification system special fund established under section 353-136;
(28) Deposit beverage container deposit special fund under section 342G-104;
(29) Hospital sustainability program special fund under section 346G-4;
(30) Nursing facility sustainability program special fund under section 346F-4;
(31) Hawaii 3R's school improvement fund under section 302A-1502.4;
(32) After-school plus program revolving fund under section 302A-1149.5;
(33) Civil monetary penalty special fund under
section 321-30.2; [and]
[[](34)[]] Stadium development special fund under
section 109-3.5[,]; and
(35) Universal immunization purchase special fund under section 325- ,
shall deduct five per cent of all receipts of all other special funds, which deduction shall be transferred to the general fund of the State and become general realizations of the State. All officers of the State and other persons having power to allocate or disburse any special funds shall cooperate with the director in effecting these transfers. To determine the proper revenue base upon which the central service assessment is to be calculated, the director shall adopt rules pursuant to chapter 91 for the purpose of suspending or limiting the application of the central service assessment of any fund. No later than twenty days prior to the convening of each regular session of the legislature, the director shall report all central service assessments made during the preceding fiscal year."
SECTION 4. There is appropriated out of the general revenues of the State of Hawaii the sum of $ or so much thereof as may be necessary for the fiscal year 2025-2026 to be deposited into the universal immunization purchase special fund.
SECTION 5. There is appropriated out of the universal immunization purchase special fund the sum of $ or so much thereof as may be necessary for fiscal year 2025-2026 for the purchase of immunizations and the administration of the the universal immunization funding program.
The sum appropriated shall be expended by the department of health for the purposes of this Act.
SECTION 6. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 7. This Act shall take effect on July 1, 3000.
Report Title:
Universal Immunization Funding Program; Immunization Purchasing; Universal Immunization Purchase Special Fund; Appropriation
Description:
Establishes the Universal Immunization Purchase Program as a universal funding model for immunization purchases by the Department of Health, to increase statewide access to immunizations for all persons under age sixty-five. Establishes the Universal Immunization Purchase Special Fund, into which fees collected from assessed entities and other sources of funding will be deposited, for purposes of bulk purchasing immunizations and administering the program. Appropriates funds. Effective 7/1/3000. (HD1)
The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
|
THE SENATE |
S.B. NO. |
1434 |
|
THIRTY-THIRD LEGISLATURE, 2025 |
S.D. 1 |
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO UNIVERSAL IMMUNIZATION FUNDING PROGRAM.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. The legislature finds that fourteen states have adopted programs known as "Universal Purchase" or "Universal Select" (collectively, UP), providing state-purchased access to some or all recommended immunizations to children and adults in those states. UP immunization purchases occur at a discounted price through contracts otherwise intended for more established and familiar immunization purchasing programs such as the Vaccines For Children Program (Public Law 103-66) and Public Health Services Act, Section 317 Immunization Program (Public Law 78-410). Other varied state approaches include superseding private sources of coverage and assessing health insurance plans for the cost of the program and disallowing provider use of private immunization stock.
The legislature further finds that states with UP programs that allow state health officials to manage the supply of immunizations lowered health care providers' administrative costs and ensured that the states can quickly supply immunizations to vulnerable patient groups during emergencies or immunization shortages. The potential benefits to Hawaii's health care and public health system make investment in a UP program worthwhile.
The purpose of this Act is to establish a universal immunization funding program in the State.
SECTION 2. Chapter 321, Hawaii Revised Statutes, is amended by adding a new part to be appropriately designated and to read as follows:
"PART . UNIVERSAL IMMUNIZATION FUNDING PROGRAM
§321- Definitions. As used in this part:
"Adult covered lives" means all adults under the age of sixty-five who have immunizations covered:
(1) By an individual health insurance policy issued or delivered in the State;
(2) By a group health insurance policy issued or delivered in the State;
(3) By a group health insurance policy evidenced by a certificate of insurance issued or delivered to an individual residing in the State;
(4) By an employee benefit plan of a self-insured entity or a government plan for any employer or government entity that has an office or other worksite located in the State or has two or more employees; or
(5) As a participant or beneficiary of a health cost sharing program.
"Assessed entity" means any health insurer in the State, that is not federally funded, issuing individual and group accident and health or sickness insurance policies, individual or group hospital or medical service plan contracts, and nonprofit mutual benefit society, fraternal benefit society, and health maintenance organization health plans.
"Assessment" means the association member liability with respect to immunization costs determined in accordance with this part.
"Child covered lives" means all children aged eighteen years or younger who have immunizations covered:
(1) By an individual health insurance policy issued or delivered in the State;
(2) By a group health insurance policy issued or delivered in the State;
(3) By a group health insurance policy evidenced by a certificate of insurance issued or delivered to an individual residing in the State;
(4) By an employee benefit plan of a self-insured entity or a government plan for any employer or government entity that has an office or other worksite located in the State or has two or more employees; or
(5) As a participant or beneficiary of a health cost sharing program.
"Department" means the department of health.
"Director" means the director of health or designee.
"Estimated adult immunization cost" means the estimated cost to the State for the purchase and distribution of adult immunizations purchased at the federal discount rate.
"Estimated child immunization cost" means the estimated cost to the State for the purchase and distribution of child immunizations purchased at the federal discount rate.
"Health insurer" means an entity subject to the insurance laws and rules of the State, or subject to the jurisdiction of the insurance commissioner, that contracts or offers to contract to provide, deliver, arrange for, pay for, or reimburse any of the costs of health care services, including an insurance company, a health maintenance organization, a mutual benefit society, or any other entity providing a plan of health insurance, health benefits, or health services.
"Health cost sharing program" means any cost sharing or similar program that seeks to share the costs of health care services and that in the preceding twelve months has either coordinated payment for or reimbursed over $10,000 of costs for health care services delivered in the State or communicated by mail or electronic media to residents of the State concerning its potential participation.
"Immunization" means any preparation of killed microorganisms, living attenuated organisms, living fully virulent organisms, or part thereof, or any other treatment intended to trigger an immune response that is authorized by the United States Food and Drug Administration, recommended by the national Advisory Committee on Immunization Practices of the federal Centers for Disease Control and Prevention, or has been authorized for purchase by the director for the purposes of producing or increasing immunity to particular diseases. "Immunization" includes any other substance designated as immunization by order of the director.
"Provider" means a person licensed by the State to administer immunizations or provide health care services or a partnership or corporation or other entity made up of those persons.
§321- Universal immunization funding program; established. (a) There is established within the department an universal immunization funding program for the purpose of administering immunizations to individuals in the State who are not eligible to receive immunizations at no cost through other programs.
(b) The department may contract with other entities for any services needed to carry out the purposes of this part.
§321- Universal immunization purchase special fund; established. (a) There is established in the state treasury the universal immunization purchase special fund into which shall be deposited fees, fines, and cost reimbursements collected from assessed entities pursuant to this part. The fund shall be administered and expended by the department.
(b) Expenditures from the fund shall be used for the purchase of immunizations and the administration of the universal immunization funding program, at no cost to providers, to administer to individuals who are not eligible to receive immunizations at no cost through other programs.
§321- Assessments. (a) The director shall determine regular immunization assessment rates as follows:
(1) Provide estimated child immunization costs and estimated adult immunization costs, not covered by any other state or federal funds, for the succeeding year no later than one hundred twenty days before the commencement of each fiscal year;
(2) Add estimates to cover the department's operating costs for the universal immunization funding program;
(3) Add a reserve of up to ten per cent of the sum of the preceding fiscal year and for unanticipated costs;
(4) Add a working capital reserve in such amount as may be reasonably determined by the director;
(5) Subtract the amount of any unexpended fund balance, including any net investment income earned, as of the end of the preceding fiscal year; and
(6) Calculate a per-child covered life per month and per-adult covered life per month amount to be self-reported and paid by all assessed entities by dividing the annual amount determined in accordance with paragraphs (1) through (5) by the number of children and adults, respectively, projected to be covered by the assessed entities during the succeeding program year, divided by twelve.
(b) No later than forty-five days following the close of the state fiscal year, the department shall provide an accounting of immunization purchase funds not covered by any state or other program to determine the final amount needed to cover the prior fiscal year.
Unless determined by the director, any assessed entity that would otherwise be responsible for reimbursement to any provider for any immunization administration shall be responsible for reporting the child covered life and adult covered life and for payment of the corresponding assessment to the department.
(c) At any time after one full calendar year of operation under subsections (a) and (b), the director may make changes to the assessment collection mechanism. Any changes shall be reflected in an updated plan of operation available to the public.
(d) If an assessed entity has not paid in accordance with this section, interest accrues at one per cent per month, compounded monthly on or after the due date.
(e) The director may determine an interim assessment for new immunizations or public health emergencies and shall calculate a supplemental interim assessment using the methodology outlined under subsection (a) for regular assessments, but payable over the remaining fiscal year, and the interim assessment shall be payable together with the regular assessment commencing the calendar quarter that begins not less than thirty days following the establishment of the federal contract price. The director may not impose more than one interim assessment per year, except in the case of a public health emergency declared in accordance with state or federal law.
(f) For purposes of assessments, medical loss ratio calculations, and reimbursement by plan sponsors, all association assessments are considered pharmaceutical or medical benefit costs and not regulatory or administrative costs.
(g) If the department discontinues operation of the universal immunization funding program for any reason, any unexpected assessments, including unexpended funds from prior assessments in the universal immunization special purchase fund, shall be refunded to payees in proportion to the respective assessment payments by payees over the most recent eight quarters before discontinuation of program operations.
§321- Reports and audits. (a) Each assessed entity shall report its number of child and adult covered lives according to a schedule determined by the director and respond to any requests by the director related to covered lives or assessments due. Any assessed entity that fails to respond to an audit request within ten business days of the receipt of notification of audit request shall be responsible for prompt payment of fees of any outside auditor engaged by the department to determine the information and shall make all records requested by the department-engaged auditors available for inspection and copying at such location within the State as specified by the auditor.
(b) Each provider administering immunizations in the State that is supplied via federal vaccination programs or the universal immunization funding program shall report to the Hawaii immunization registry pursuant to section 325-122, any data related to immunizations as the department determines is necessary for disease prevention, control, and immunization inventory management and accountability purposes.
(c) Failure to cure non-compliance with any reporting, auditing, or assessment obligation to the department no later than thirty days from the postmarked date of written notice of noncompliance may subject the assessed entity to fines established pursuant to subsection (d). Any monetary fine, fee, or cost reimbursement shall be remitted to the universal immunization purchase special fund.
(d) Any entity that violates this chapter shall be fined not more than $1,000 for each separate offense. Each day of violation shall constitute a separate offense. The assessed entity shall also pay for reasonable attorneys' fees and any other costs of enforcement under this section. Any action taken to impose or collect the penalty provided for in this subsection shall be considered a civil action.
§321- Immunity. Apart from liabilities of assessed entities pursuant to this part, there shall be no liability on the part of and no cause of action against the department, its independent contractors, or its employees for any action or omission in the course of operating the universal immunization purchase program.
§321- Rulemaking. The department may adopt rules pursuant to chapter 91 to carry out the purposes of this part.
§321- Available choices. The department shall maintain a list of immunizations, including all brand choices available for purchase by the State on the federal Centers for Disease Control and Prevention contract, for which costs are funded pursuant to this part.
§321- Immunization cost reimbursement to providers; limits. This part shall have no impact on amounts paid to providers to administer immunizations. No provider may bill any assessed entity or any other person for any immunizations supplied at no cost by the State."
SECTION 3. There is appropriated out of the general revenues of the State of Hawaii the sum of $ or so much thereof as may be necessary for the fiscal year 2025-2026 to be deposited into the universal immunization purchase special fund.
SECTION 4. There is appropriated out of the universal immunization purchase special fund the sum of $ or so much thereof as may be necessary for fiscal year 2025-2026 for startup operations and initial procurements for the universal immunization funding program.
The sum appropriated shall be expended by the department of health for the purposes of this Act.
SECTION 5. This Act shall take effect on December 31, 2050.
Report Title:
Universal Immunization Funding Program; Immunization Purchasing; Universal Immunization Purchase Special Fund; Appropriations
Description:
Establishes the Universal Immunization Funding Program for the purpose of administering immunizations to individuals in the State who are not eligible to receive immunizations at no cost through other programs. Establishes the Universal Immunization Purchase Special Fund into which fees will be deposited to finance the Universal Immunization Funding Program. Effective 12/31/2050. (SD1)
The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
|
THE SENATE |
S.B. NO. |
1434 |
|
THIRTY-THIRD LEGISLATURE, 2025 |
|
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO UNIVERSAL IMMUNIZATION FUNDING PROGRAM.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. The legislature finds that fourteen states have adopted programs known as "Universal Purchase" or "Universal Select" (collectively, UP), providing state-purchased access to some or all recommended immunizations to children and adults in those states. UP immunization purchases occur at a discounted price through contracts otherwise intended for more established and familiar immunization purchasing programs such as the Vaccines For Children Program (Pub. L. 103-66) and Public Health Services Act, Section 317 Immunization Program (Pub. L. 78-410). Other varied state approaches include superseding private sources of coverage and assessing health insurance plans for the cost of the program and disallowing provider use of private immunization stock.
The legislature further finds that states with UP programs that allow state health officials to manage the supply of immunizations lowered health care providers' administrative costs and ensured that the states can quickly supply immunizations to vulnerable patient groups during emergencies or immunization shortages. The potential benefits to Hawaii's health care and public health system make investment in a UP program worthwhile.
SECTION 2. Chapter 321, Hawaii Revised Statutes, is amended by adding a new part to be appropriately designated and to read as follows:
"PART . UNIVERSAL IMMUNIZATION FUNDING PROGRAM
§321- Definitions. As used in this part, unless the context otherwise requires:
"Adult covered lives" means all adults under the age of sixty-five who have immunizations covered:
(1) By an individual health insurance policy issued or delivered in the State;
(2) By a group health insurance policy issued or delivered in the State;
(3) By a group health insurance policy evidenced by a certificate of insurance issued or delivered to an individual residing in the State;
(4) By an employee benefit plan of a self-insured entity or a government plan for any employer or government entity that has an office or other worksite located in the State or has two or more employees; or
(5) As a participant or beneficiary of a health cost sharing program.
"Assessed entity" means any insurer in the State, that is not federally funded, issuing individual and group accident and health or sickness insurance policies, individual or group hospital or medical service plan contracts, and nonprofit mutual benefit society, fraternal benefit society, and health maintenance organization health plans.
"Assessment" means the association member liability with respect to immunization costs determined in accordance with this part.
"Child covered lives" means all children aged eighteen years or younger who have immunizations covered:
(1) By an individual health insurance policy issued or delivered in the State;
(2) By a group health insurance policy issued or delivered in the State;
(3) By a group health insurance policy evidenced by a certificate of insurance issued or delivered to an individual residing in the State;
(4) By an employee benefit plan of a self-insured entity or a government plan for any employer or government entity that has an office or other worksite located in the State or has two or more employees; or
(5) As a participant or beneficiary of a health cost sharing program.
"Department" means the department of health.
"Director" means the director of health or designee.
"Estimated adult immunization cost" means the estimated cost to the State for the purchase and distribution of adult immunizations purchased at the federal discount rate.
"Estimated pediatric immunization cost" means the estimated cost to the State for the purchase and distribution of child immunizations purchased at the federal discount rate.
"Health carrier" means an entity subject to the insurance laws and rules of the State, or subject to the jurisdiction of the insurance commissioner, that contracts or offers to contract to provide, deliver, arrange for, pay for, or reimburse any of the costs of health care services, including an insurance company, a health maintenance organization, a mutual benefit society, or any other entity providing a plan of health insurance, health benefits, or health services.
"Health cost sharing program" means any cost sharing or similar program that seeks to share the costs of health care services and that in the preceding twelve months either has coordinated payment for or reimbursed over $10,000 of costs for health care services delivered in the State or communicated by mail or electronic media to residents of the State concerning their potential participation.
"Immunization" means any preparation of killed microorganisms, living attenuated organisms, or living fully virulent organisms of mRNA or any other injectable treatment intended to trigger an immune response that is authorized by the United States Food and Drug Administration and recommended by the national Advisory Committee on Immunization Practices of the United States Centers for Disease Control and Prevention and has been authorized for purchase by the director for the purposes of producing or artificially increasing immunity to particular diseases. For purposes of this part, "immunization" shall include any other substance designated as such by order of the director.
"Provider" means a person licensed by the State to administer immunizations or provide health care services or a partnership or corporation or other entity made up of those persons.
§321- Universal immunization purchase special fund; established. (a) There is established in the state treasury the universal immunization purchase special fund into which shall be deposited fees, fines, and cost reimbursements paid by assessed entities. The fund shall be administered and expended by the department.
(b) Expenditures from the fund shall be used for the purchase of immunizations and the administration of the program, at no cost to providers, to administer to individuals who are not eligible to receive immunizations at no cost through other programs.
(c) The department may contract with other entities for any services pursuant to this part.
§321- Assessments. (a) The director shall determine regular immunization assessment rates as follows:
(1) Provide estimated child immunization costs and estimated adult immunization costs, not covered by any other state or federal funds, for the succeeding year no later than one hundred twenty days prior to the commencement of each fiscal year;
(2) Add estimates to cover the department's operating costs for the universal immunization purchase special fund program;
(3) Add a reserve of up to ten per cent of the sum of the preceding fiscal year and for unanticipated costs;
(4) Add a working capital reserve in such amount as may be reasonably determined by the director;
(5) Subtract the amount of any unexpended fund balance, including any net investment income earned, as of the end of the preceding fiscal year; and
(6) Calculate a per-child covered life per month and per-adult covered life per month amount to be self-reported and paid by all assessed entities by dividing the annual amount determined in accordance with paragraphs (1) through (5) by the number of children and adults, respectively, projected to be covered by the assessed entities during the succeeding program year, divided by twelve.
(b) No later than forty-five days following the close of the state fiscal year, the department shall provide an accounting of immunization purchase funds not covered by any state or other program to determine the final amount needed to cover the prior fiscal year.
Unless determined by the director, any assessed entity that would otherwise be responsible for reimbursement to any provider for any immunization administration shall be responsible for reporting the child covered life and adult covered life and for payment of the corresponding assessment to the department.
(c) At any time after one full calendar year of operation under subsections (a) and (b), the director may make changes to the assessment collection mechanism. Any such changes shall be reflected in an updated plan of operation available to the public.
(d) If an assessed entity has not paid in accordance with this section, interest accrues at one per cent per month, compounded monthly on or after the due date.
(e) The director may determine an interim assessment for new immunizations or public health emergencies and shall calculate a supplemental interim assessment using the methodology outlined under subsection (a) for regular assessments, but payable over the remaining fiscal year, and such interim assessment shall be payable together with the regular assessment commencing the calendar quarter that begins no less than thirty days following the establishment of the federal contract price. The director may not impose more than one interim assessment per year, except in the case of a public health emergency declared in accordance with state or federal law.
(f) For purposes of assessments, medical loss ratio calculations, and reimbursement by plan sponsors, all association assessments are considered pharmaceutical or medical benefit costs and not regulatory or administrative costs.
(g) If the department discontinues operation of the universal immunization funding program for any reason, any unexpected assessments, including unexpended funds from prior assessments in the immunization purchase fund, shall be refunded to payees in proportion to the respective assessment payments by payees over the most recent eight quarters before discontinuation of program operations.
§321- Reports and audits. (a) Each assessed entity shall report its number of child and adult covered lives according to a schedule determined by the director and respond to any requests by the director related to covered lives or assessments due. Any assessed entity that fails to respond to an audit request within ten business days of the receipt of notification of audit request shall be responsible for prompt payment of fees of any outside auditor engaged by the department to determine such information and shall make all records requested by the department-engaged auditors available for inspection and copying at such location within the State as specified by the auditor.
(b) Each provider administering immunizations in the State that are supplied via federal vaccination programs or the universal immunization funding program shall report to the Hawaii immunization registry pursuant to section 325-122, such data related to immunizations as the department determines is necessary for disease prevention, control, and immunization inventory management and accountability purposes.
(c) Failure to cure non-compliance with any reporting, auditing, or assessment obligation to the department within thirty days from the postmarked date of written notice of noncompliance may subject the assessed entity to fines established pursuant to subsection (d). Any monetary fine, fee, or cost reimbursement shall be remitted to the universal immunization purchase special fund.
(d) Any entity that violates this chapter shall be fined no more than $1,000 for each separate offense. Each date of violation shall constitute a separate offense. The assessed entity shall also pay for reasonable attorney's fees and any other costs of enforcement under this section. Any action taken to impose or collect the penalty provided for in this subsection shall be considered a civil action.
§321- Immunity. Apart from liabilities of assessed entities pursuant to this part, there shall be no liability on the part of and no cause of action against the department, independent contractors, or employees for any action or omission in the course of operating the universal immunization purchase program.
§321- Rulemaking. The department may adopt rules pursuant to chapter 91 to carry out the purposes of this part.
§321- Available choices. The department shall maintain a list of immunizations, including all brand choices available for purchase by the State on the United States Centers for Disease Control and Prevention contract, for which costs are funded pursuant to this part.
§321- Immunization cost reimbursement to providers; limits. This part shall have no impact on amounts paid to providers to administer immunizations. No provider may bill any assessed entity or any other person for any immunizations supplied at no cost by the State."
SECTION 3. There is appropriated out of the general revenues of the State of Hawaii the sum of $__________ or so much thereof as may be necessary for the fiscal year 2025-2026 to be deposited into the universal immunization purchase special fund.
SECTION 4. There is appropriated out of the universal immunization purchase special fund the sum of $__________ or so much thereof as may be necessary for fiscal year 2025-2026 for startup operations and initial procurements for the universal immunization funding program.
The sum appropriated shall be expended by the department of health for the purposes of this Act.
SECTION 5. This Act, upon its approval, shall take effect on July 1, 2025.
|
INTRODUCED BY: |
_____________________________ |
|
|
BY REQUEST |
Report Title:
Universal Immunization Funding Program; Immunization Purchasing; Universal Immunization Purchase Special Fund
Description:
Establishes the Universal Immunization Purchase Special Fund into which the fees will be deposited to finance the distribution of immunizations free of charge to qualifying healthcare providers.
The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
|
Date
|
Status
|
|---|---|
| Jun 4, 2025 | Act 175, on 06/04/2025 (Gov. Msg. No. 1275). |
| Jun 4, 2025 | Act 175, 06/04/2025 (Gov. Msg. No. 1275). |
| May 2, 2025 | Enrolled to Governor. |
| May 2, 2025 | Received notice of passage on Final Reading in House (Hse. Com. No. 824). |
| May 2, 2025 | Received notice of Final Reading (Sen. Com. No. 889). |
| May 2, 2025 | Passed Final Reading as amended in CD 2 with none voting aye with reservations; Representative(s) Alcos, Garcia, Kila, Kong, Matsumoto, Muraoka, Pierick, Reyes Oda, Shimizu voting no (9) and Representative(s) Cochran, Iwamoto excused (2). |
| May 2, 2025 | Passed Final Reading, as amended (CD 2). Ayes, 23; Aye(s) with reservations: none. Noes, 2 (Senator(s) Awa, DeCorte). Excused, 0 (none). |
| Apr 30, 2025 | 48 Hrs. Notice 05-02-25 |
| Apr 30, 2025 | Report filed. |
| Apr 30, 2025 | Separated Committee Report. |
| Apr 30, 2025 | Floor amendment adopted as amended (CD 2). |
| Apr 30, 2025 | Floor Amendment No. 13 offered. |
| Apr 30, 2025 | Forty-eight (48) hours notice Friday, 05-02-25. |
| Apr 30, 2025 | Floor amendment adopted as amended CD 2 with none voting no and Representative(s) Cochran excused. |
| Apr 30, 2025 | Floor Amendment No. 5 offered by Rep. Takayama. |
| Apr 25, 2025 | Forty-eight (48) hours notice Wednesday, 04-30-25. |
| Apr 25, 2025 | Reported from Conference Committee (Conf Com. Rep. No. 198) as amended in (CD 1). |
| Apr 25, 2025 | 48 Hrs. Notice (as amended CD 1) 04-30-25. |
| Apr 25, 2025 | Reported from Conference Committee as amended CD 1 (Conf. Com. Rep. No. 198). |
| Apr 25, 2025 | The Conference Committee recommends that the measure be Passed, with Amendments. The votes were as follows: 2 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy; Ayes with reservations: none; 1 Noes: Representative(s) Alcos; and 0 Excused: none. |
| Apr 25, 2025 | The Conference committee recommends that the measure be PASSED, WITH AMENDMENTS. The votes of the Senate Conference Managers were as follows: 4 Aye(s): Senator(s) San Buenaventura, Inouye, Aquino, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none. |
| Apr 25, 2025 | Received notice of change in Senate conferees (Sen. Com. No. 882). |
| Apr 25, 2025 | Senate Conferees Changed: Senator Aquino added as Conferee. Senator Hashimoto discharged as Conferee. |
| Apr 25, 2025 | Conference committee meeting to reconvene on 04-25-25 5:20 PM; Conference Room 329. |
| Apr 24, 2025 | Conference committee meeting to reconvene on 04-25-25 3:30PM; Conference Room 329. |
| Apr 23, 2025 | Conference committee meeting to reconvene on 04-24-25 3:30PM; Conference Room 329. |
| Apr 22, 2025 | Conference committee meeting scheduled for 04-23-25 3:30PM; Conference Room 329. |
| Apr 15, 2025 | Received notice of Senate conferees (Sen. Com. No. 789). |
| Apr 15, 2025 | Senate Conferees Appointed: San Buenaventura Chair; Inouye Co-Chair; Hashimoto, Fevella. |
| Apr 15, 2025 | Received notice of appointment of House conferees (Hse. Com. No. 731). |
| Apr 14, 2025 | House Conferees Appointed: Takayama, Keohokapu-Lee Loy Co-Chairs; Alcos. |
| Apr 4, 2025 | Received notice of disagreement (Sen. Com. No. 590). |
| Apr 4, 2025 | Senate disagrees with House amendments. |
| Apr 4, 2025 | Received from House (Hse. Com. No. 490). |
| Apr 3, 2025 | Passed Third Reading with none voting aye with reservations; Representative(s) Alcos, Garcia, Kong, Matsumoto, Muraoka, Pierick, Reyes Oda, Shimizu voting no (8) and Representative(s) Cochran, Woodson excused (2). Transmitted to Senate. |
| Apr 3, 2025 | Reported from FIN (Stand. Com. Rep. No. 1932), recommending passage on Third Reading. |
| Mar 28, 2025 | The committee on FIN recommend that the measure be PASSED, UNAMENDED. The votes were as follows: 12 Ayes: Representative(s) Yamashita, Takenouchi, Grandinetti, Holt, Keohokapu-Lee Loy, Kitagawa, Kusch, Lamosao, Lee, M., Miyake, Morikawa, Templo; Ayes with reservations: none; 2 Noes: Representative(s) Alcos, Reyes Oda; and 2 Excused: Representative(s) Hussey, Ward. |
| Mar 25, 2025 | Bill scheduled to be heard by FIN on Friday, 03-28-25 2:00PM in House conference room 308 VIA VIDEOCONFERENCE. |
| Mar 18, 2025 | Passed Second Reading as amended in HD 1 and referred to the committee(s) on FIN with none voting aye with reservations; Representative(s) Alcos, Garcia, Kong, Matsumoto, Muraoka, Pierick, Reyes Oda, Shimizu voting no (8) and Representative(s) Cochran, Ward excused (2). |
| Mar 18, 2025 | Reported from HLT (Stand. Com. Rep. No. 1314) as amended in HD 1, recommending passage on Second Reading and referral to FIN. |
| Mar 14, 2025 | The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 7 Ayes: Representative(s) Takayama, Keohokapu-Lee Loy, Amato, Chun, Marten, Takenouchi; Ayes with reservations: Representative(s) Olds; 2 Noes: Representative(s) Alcos, Garcia; and 0 Excused: none. |
| Mar 11, 2025 | Bill scheduled to be heard by HLT on Friday, 03-14-25 9:00AM in House conference room 329 VIA VIDEOCONFERENCE. |
| Mar 6, 2025 | Referred to HLT, FIN, referral sheet 19 |
| Mar 6, 2025 | Pass First Reading |
| Mar 4, 2025 | Received from Senate (Sen. Com. No. 333) in amended form (SD 1). |
| Mar 4, 2025 | Report Adopted; Passed Third Reading. Ayes, 23; Aye(s) with reservations: none. Noes, 2 (Senator(s) Awa, DeCorte). Excused, 0 (none). Transmitted to House. |
| Feb 28, 2025 | One Day Notice 03-04-25. |
| Feb 28, 2025 | Reported from WAM (Stand. Com. Rep. No. 1035) with recommendation of passage on Third Reading. |
| Feb 28, 2025 | The committee(s) on WAM recommend(s) that the measure be PASSED, UNAMENDED. The votes in WAM were as follows: 10 Aye(s): Senator(s) Dela Cruz, Moriwaki, Aquino, DeCoite, Elefante, Hashimoto, Inouye, Kanuha, Wakai, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 3 Excused: Senator(s) Kidani, Kim, Lee, C.. |
| Feb 27, 2025 | Public notice requirement waived pursuant to Senate Rule 21. |
| Feb 26, 2025 | The committee(s) on WAM will hold a public decision making on 02-28-25 10:05AM; Conference Room 211 & Videoconference. |
| Feb 13, 2025 | Report adopted; Passed Second Reading, as amended (SD 1) and referred to WAM. |
| Feb 13, 2025 | Reported from HHS (Stand. Com. Rep. No. 424) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM. |
| Feb 3, 2025 | The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, Aquino, Hashimoto, Keohokalole, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none. |
| Jan 31, 2025 | The committee(s) on HHS has scheduled a public hearing on 02-03-25 1:00PM; Conference Room 225 & Videoconference. |
| Jan 27, 2025 | Referred to HHS, WAM. |
| Jan 23, 2025 | Introduced and passed First Reading. |
| Jan 21, 2025 | Pending Introduction. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| May 2, 2025 | Final Reading | House Floor |
Passed |
|
| May 2, 2025 | Final Reading | Senate Floor |
Passed |
|
| Apr 3, 2025 | Third Reading | House Floor |
Passed |
|
| Mar 28, 2025 | The committee on FIN recommend that the measure be PASSED, UNAMENDED | House Standing Committee on Finance |
Passed |
|
| Mar 14, 2025 | The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS | House Standing Committee on Health |
Passed |
|
| Mar 4, 2025 | Third Reading | Senate Floor |
Passed |
|
| Feb 28, 2025 | The committee(s) on WAM recommend(s) that the measure be PASSED, UNAMENDED | Senate Standing Committee on Ways and Means |
Passed |
|
| Feb 3, 2025 | The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS | Senate Standing Committee on Health and Human Services |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| 3-G International, Inc. | ** Against | |
| Aloha Ambassador, *CHOOSE ALOHA* Program | *** Against | Feb 3, 2025 |
| Aloha Freedom Coalition | *** Against | Mar 28, 2025 |
| AlohaCare | ** Support | |
| AlohaCare | *** Support | Mar 28, 2025 |
| American Academy of Pediatrics, Hawaiʻi Chapter | ** Support | |
| Biotechnology Innovation Organization (BIO) | *** Against | Mar 14, 2025 |
| Democratic Party of Hawaiʻi | ** Support | |
| Department of Health | ** Support | |
| Free Citizens of Maunalua | *** Against | Mar 28, 2025 |
| Hawaii General Jural Assembly | *** Against | Mar 28, 2025 |
| Hawaii Medical Service Association | ** Support | |
| Hawaii Medical Association | ** Support | |
| Hawaii Medical Service Association (HMSA) | *** Support | Mar 14, 2025 |
| Hawaii Patriot Republicans | *** Against | Mar 28, 2025 |
| Hawaiian Islands Republican Women | *** Against | Mar 28, 2025 |
| Hawaiʻi Academy of Family Physicians | ** Support | |
| Hawaiʻi Public Health Institute | ** Support | |
| Hawaiʻi American Nurses Association | ** Support | |
| Hawai’i Christian Coalition | *** Against | Mar 28, 2025 |
| Healthcare Association of Hawaii | ** Support | |
| HOPE HI, Inc. | *** Against | Feb 28, 2025 |
| Libertarian Party of Hawaii | *** Against | Mar 28, 2025 |
| President, H.O.P.E. HI, Inc. | *** Against | Feb 3, 2025 |
| Queens Health System | *** Support | Feb 28, 2025 |
| State Health Planning and Development Agency | ** Support | |
| Tax Foundation of Hawaii | *** Against | Mar 28, 2025 |
| The Libertarian Party of Hawaii | *** Against | Mar 28, 2025 |
| Wai’anae resident, District 45 | *** Against | Mar 28, 2025 |
CONFERENCE COMMITTEE REP. NO. 198
Honolulu, Hawaii
, 2025
RE: S.B. No. 1434
S.D. 1
H.D. 1
C.D. 1
Honorable Ronald D. Kouchi
President of the Senate
Thirty-Third State Legislature
Regular Session of 2025
State of Hawaii
Honorable Nadine K. Nakamura
Speaker, House of Representatives
Thirty-Third State Legislature
Regular Session of 2025
State of Hawaii
Sir and Madam:
Your Committee on Conference on the disagreeing vote of the Senate to the amendments proposed by the House of Representatives in S.B. No. 1434, S.D. 1, H.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO UNIVERSAL IMMUNIZATION FUNDING PROGRAM,"
having met, and after full and free discussion, has agreed to recommend and does recommend to the respective Houses the final passage of this bill in an amended form.
The purpose of this measure is to:
(1) Establish the Universal Immunization Funding Program as a universal funding model for immunization purchases by the Department of Health, to increase statewide access to immunizations for all persons under age sixty-five; and
(2) Establish the Universal Immunization Purchase Special Fund, into which fees collected from assessed entities and other sources of funding will be deposited, for purposes of bulk purchasing immunizations and administering the program.
Your Committee on Conference finds that "Universal Purchase" or "Universal Select" (collectively, UP) programs are programs that enable states to leverage bulk purchasing and federal immunization programs to establish a streamlined procurement, oversight, and distribution system for all recommended vaccines for children and adults. Your Committee on Conference further finds that providers currently take on considerable risk because of the need to pay for their private sector immunization supplies up front, as well as incurring other expenses such as secure and temperature-controlled storage. By centralizing public and private sector immunization procurement and leveraging bulk purchasing power through federal or state consortium contracts, this measure lowers private-sector costs and improves access to needed immunizations for all keiki, families, and communities statewide.
Your Committee on Conference has amended this measure by:
(1) Deleting language that would have appropriated funds out of the general revenues of the state to be deposited into the Universal Immunization Purchase Special Fund;
(2) Inserting an appropriation amount of $934,000 out of the Universal Immunization Purchase Special Fund for fiscal year 2025-2026 to be expended by the Department of Health for the purchase of immunizations and the administration of the Universal Immunization Funding Program;
(3) Changing the effective date to July 1, 2025; and
(4) Making technical, nonsubstantive amendments for the purposes of clarity and consistency.
As affirmed by the record of votes of the managers of your Committee on Conference that is attached to this report, your Committee on Conference is in accord with the intent and purpose of S.B. No. 1434, S.D. 1, H.D. 1, as amended herein, and recommends that it pass Final Reading in the form attached hereto as S.B. No. 1434, S.D. 1, H.D. 1, C.D. 1.
Respectfully submitted on behalf of the managers:
|
ON THE PART OF THE HOUSE |
|
ON THE PART OF THE SENATE |
|
____________________________ GREGG TAKAYAMA Co-Chair |
|
____________________________ JOY A. SAN BUENAVENTURA Chair |
|
____________________________ SUE L. KEOHOKAPU-LEE LOY Co-Chair |
|
____________________________ LORRAINE R. INOUYE Co-Chair |
|
|
|
|
|
|
|
|
STAND. COM. REP. NO. 1932
Honolulu, Hawaii
, 2025
RE: S.B. No. 1434
S.D. 1
H.D. 1
Honorable Nadine K. Nakamura
Speaker, House of Representatives
Thirty-Third State Legislature
Regular Session of 2025
State of Hawaii
Madame:
Your Committee on Finance, to which was referred S.B. No. 1434, S.D. 1, H.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO UNIVERSAL IMMUNIZATION FUNDING PROGRAM,"
begs leave to report as follows:
The purpose of this measure is to:
(1) Establish a Universal Immunization Funding Program for all individuals in the State; and
(2) Establish and appropriate funds into and out of the Universal Immunization Purchase Special Fund for the purchase of immunizations and administration of the Universal Immunization Funding Program.
Your Committee received testimony in support of this measure from the Department of Health; State Health Planning and Development Agency; Healthcare Association of Hawaii; Hawaiʻi Public Health Institute; Hawaiʻi American Nurses Association; American Academy of Pediatrics, Hawaiʻi Chapter; Hawaii Medical Association; AlohaCare; and numerous individuals. Your Committee received testimony in opposition to this measure from the Libertarian Party of Hawaii; Hawaiian Islands Republican Women; Aloha Freedom Coalition; Hawaiʻi Christian Coalition; Hawaii Patriot Republicans; Free Citizens of Maunalua; Hawaii General Jural Assembly; and numerous individuals. Your Committee received comments on this measure from the Tax Foundation of Hawaii.
As affirmed by the record of votes of the members of your Committee on Finance that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 1434, S.D. 1, H.D. 1, and recommends that it pass Third Reading.
Respectfully submitted on behalf of the members of the Committee on Finance,
|
|
|
____________________________ KYLE T. YAMASHITA, Chair |
|
|
|
|
STAND. COM. REP. NO. 1314
Honolulu, Hawaii
, 2025
RE: S.B. No. 1434
S.D. 1
H.D. 1
Honorable Nadine K. Nakamura
Speaker, House of Representatives
Thirty-Third State Legislature
Regular Session of 2025
State of Hawaii
Madame:
Your Committee on Health, to which was referred S.B. No. 1434, S.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO UNIVERSAL IMMUNIZATION FUNDING PROGRAM,"
begs leave to report as follows:
The purpose of this measure is to establish a Universal Immunization Funding Program in the State.
Your Committee received testimony in support of this measure from the Department of Health; Hawaiʻi Academy of Family Physicians; Healthcare Association of Hawaii; AlohaCare; Hawaii Medical Association; Hawaii Medical Service Association; American Academy of Pediatrics Hawaii Chapter; Hawaii Public Health Institute; and numerous individuals. Your Committee received testimony in opposition to this measure from the Hawaii Patriot Republicans; Libertarian Party of Hawaii; Biotechnology Innovation Organization; Hawaii Christian Coalition; and numerous individuals. Your Committee received comments on this measure from the Tax Foundation of Hawaii.
Your Committee finds that "Universal Purchase" programs are programs that enable states to leverage bulk purchasing and federal immunization programs to establish a streamlined procurement, oversight, and distribution system for all recommended vaccines for children and adults. Your Committee further finds that the purchase of immunizations is done by the State and private health care providers or health systems. This practice requires private health care providers to take on considerable costs, as they must pay for their immunizations up front in addition to costs incurred for securing and storing the immunizations. Your Committee believes that establishing a Universal Immunization Funding Program in Hawaii will reduce the financial and administrative burden borne by private health care providers and systems and lower incidences of immunization-preventable diseases by increasing access to immunizations.
Your Committee has amended this measure by:
(1) Placing the new statutory language establishing the Universal Immunization Funding Program in Chapter 325, Hawaii Revised Statutes, relating to infectious and communicable diseases, rather than Chapter 321, Hawaii Revised Statutes, relating to health;
(2) Amending the definitions of "assessed entity", "estimated adult immunization cost", and "estimated child immunization cost";
(3) Deleting the definition of "health insurer";
(4) Inserting definitions for "program" and "vaccines for children program";
(5) Expanding the purpose of the Universal Immunization Funding Program to include the provision of immunizations to all individuals in the State, rather than just individuals who are ineligible to receive immunizations at no cost through other programs;
(6) Amending the permissible sources of funding for the Universal Immunization Purchase Special Fund;
(7) Amending the methodology used by the Director of Health to determine immunization assessment rates;
(8) Requiring the Department of Health to audit assessed entities and providers in accordance with the reporting and compliance standards of the Universal Immunization Funding Program;
(9) Clarifying the methodology used by the Department of Health for selecting and purchasing immunizations;
(10) Exempting the Universal Immunization Purchase Special Fund from the transfer of special funds for central service expenses;
(11) Clarifying that the appropriation out of the Universal Immunization Purchase Special Fund includes the purchase of immunizations as well as administrative costs for the Universal Immunization Purchase Program;
(12) Changing the effective date to July 1, 3000, to encourage further discussion; and
(13) Making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style.
Your Committee respectfully requests your Committee on Finance, should it deliberate on this measure, to consider an appropriation amount of $934,000 into the Universal Immunization Purchase Special Fund.
As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 1434, S.D. 1, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 1434, S.D. 1, H.D. 1, and be referred to your Committee on Finance.
Respectfully submitted on behalf of the members of the Committee on Health,
|
|
|
____________________________ GREGG TAKAYAMA, Chair |
STAND. COM. REP. NO. 1035
Honolulu, Hawaii
RE: S.B. No. 1434
S.D. 1
Honorable Ronald D. Kouchi
President of the Senate
Thirty-Third State Legislature
Regular Session of 2025
State of Hawaii
Sir:
Your Committee on Ways and Means, to which was referred S.B. No. 1434, S.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO UNIVERSAL IMMUNIZATION FUNDING PROGRAM,"
begs leave to report as follows:
The purpose and intent of this measure is to facilitate immunizations among residents.
Specifically, the measure:
(1) Establishes within the Department of Health a Universal Immunization Funding Program to administer immunizations to individuals in the State who are not eligible to receive free immunizations through other programs;
(2) Establishes the universal immunization purchase special fund, from which expenditures shall be used for the purchase of immunizations and the administration of the Universal Immunization Funding Program; and
(3) Appropriates moneys into and out of the universal immunization purchase special fund.
Your Committee received written comments in support of this measure from the Department of Health; State Health Planning and Development Agency; American Academy of Pediatrics, Hawaii Chapter; and numerous individuals.
Your Committee received written comments in opposition to this measure from the Hawaiian Islands Republican Women, Libertarian Party of Hawaii, Free Citizens of Maunalua, Aloha Freedom Coalition, and numerous individuals.
Your Committee received written comments on this measure from the Tax Foundation of Hawaii.
Your Committee finds that fourteen states provide state‑purchased access to recommended immunizations, ensuring the timely supply of immunizations to vulnerable patients during emergencies or immunization shortages. Your Committee believes that this measure will help the State accomplish the same goal, address disparities in access to immunizations, and reinforce the State's commitment to promoting public health.
As affirmed by the record of votes of the members of your Committee on Ways and Means that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 1434, S.D. 1, and recommends that it pass Third Reading.
Respectfully submitted on behalf of the members of the Committee on Ways and Means,
|
|
|
________________________________ DONOVAN M. DELA CRUZ, Chair |
|
|
|
|
STAND. COM. REP. NO. 424
Honolulu, Hawaii
RE: S.B. No. 1434
S.D. 1
Honorable Ronald D. Kouchi
President of the Senate
Thirty-Third State Legislature
Regular Session of 2025
State of Hawaii
Sir:
Your Committee on Health and Human Services, to which was referred S.B. No. 1434 entitled:
"A BILL FOR AN ACT RELATING TO UNIVERSAL IMMUNIZATION FUNDING PROGRAM,"
begs leave to report as follows:
The purpose and intent of this measure is to:
(1) Establish the Universal Immunization Funding Program for the purpose of administering immunizations to individuals in the State who are not eligible to receive immunizations at no cost through other programs; and
(2) Establish the Universal Immunization Purchase Special Fund into which fees will be deposited to finance the Universal Immunization Funding Program.
Your Committee received testimony in support of this measure from the Department of Health, American Academy of Pediatrics-Hawaii Chapter, Democratic Party of Hawaiʻi, and four individuals.
Your Committee received testimony in opposition to this measure from Aloha Freedom Coalition; 3-G International, Inc.; and one hundred seventy-three individuals.
Your Committee received comments on this measure from the Tax Foundation of Hawaii.
Your Committee finds that fourteen states have adopted programs known as "Universal Purchase" or "Universal Select" (collectively, UP) programs, providing state-purchased access to some or all recommended immunizations to children and adults in those states. Your Committee further finds that states with UP programs that allow state health officials to manage the supply of immunizations lowered health care providers' administrative costs and ensured that the states can quickly supply immunizations to vulnerable patient groups during emergencies or immunization shortages. This measure addresses the increasing disparities between publicly and privately insured individuals' access to immunizations and reinforces the State's commitment to preventive health care, cost-effective public-health infrastructure, and data-driven decision-making.
Your Committee has amended this measure by:
(1) Clarifying that the definition of "immunization" means any preparation of killed microorganisms, living attenuated organisms, living fully virulent organisms, or part thereof, or any other treatment intended to trigger an immune response that is authorized by the United States Food and Drug Administration, recommended by the national Advisory Committee on Immunization Practices of the federal Centers for Disease Control and Prevention, or has been authorized for purchase by the Director of Health for the purposes of producing or increasing immunity to particular diseases, and that "immunization" includes any other substance designated as immunization by order of the Director;
(2) Inserting a new section to establish the Universal Immunization Funding Program;
(3) Amending section 1 to reflect its amended purpose;
(4) Inserting an effective date of December 31, 2050, to encourage further discussion; and
(5) Making technical, nonsubstantive amendments for the purposes of clarity and consistency.
Your Committee notes that this measure, as amended, contains an unspecified appropriation amount. Should your Committee on Ways and Means choose to deliberate on this measure, your Committee respectfully requests that it consider inserting an appropriation amount of $934,000 for startup operations and initial procurements for the Universal Immunization Funding Program.
As affirmed by the record of votes of the members of your Committee on Health and Human Services that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 1434, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 1434, S.D. 1, and be referred to your Committee on Ways and Means.
Respectfully submitted on behalf of the members of the Committee on Health and Human Services,
|
|
|
________________________________ JOY A. SAN BUENAVENTURA, Chair |
|
|
|
|
|
Date
|
Testimony PDF
|
|---|---|
| Mar 28, 2025 | SB1434_HD1_TESTIMONY_FIN_03-28-25_.PDF |
| Mar 14, 2025 | SB1434_SD1_TESTIMONY_HLT_03-14-25_.PDF |
| Feb 28, 2025 | SB1434_SD1_TESTIMONY_WAM_02-28-25_.PDF |
| Feb 3, 2025 | SB1434_TESTIMONY_HHS_02-03-25_.PDF |
Discussed in Hearing
House Floor
House Floor
Senate Floor
Conference Committee
Conference Committee
Conference Committee
Conference Committee
House Floor
Bill Author
Bill Co-Author(s):